Status:
UNKNOWN
Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa
Lead Sponsor:
Chaitanya Hospital, Pune
Conditions:
Retinitis Pigmentosa
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Retinitis pigmentosa is an eye disease in which there is damage to the retina. The retina is the layer of tissue at the back of the inner eye that converts light images to nerve signals and sends them...
Detailed Description
This study will involve about 8 visits over 1½ years .Each participant will be enrolled in study as per inclusion and exclusion criteria .Informed consent will be taken from subject before including i...
Eligibility Criteria
Inclusion
- Age 18-65
- Diagnosis of retinitis pigmentosa
- willingness to undergo Bone marrow and umbilical cord derived Mesenchymal stem cell transplantation.
- To give an informed consent as well as sign the required Informed Consent Form (ICF) for the study.
- willingness to regularly visit the hospital / clinic for follow up during the follow up period / on prior agreed time points as per the protocol.
Exclusion
- Positive test results for HIV and AIDS complex ,HCV (hepatitis C virus ), HbsAg and Syphilis
- Women who are pregnant or lactating
- Complications of diabetic retinopathy.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2016
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01914913
Start Date
September 1 2014
End Date
November 1 2016
Last Update
September 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chaitanya Hospital
Pune, Maharashtra, India, 411030